Session Type
Meeting
Search Results for Encephalopathy
Abstract Number: 29
SHM Converge 2023
Case Presentation: A 16 year old boy with obesity presented for dehydration in the setting of three months of abdominal pain, nausea, and non-bloody, non-bilious emesis. Outpatient work-up had been unrevealing. He also endorsed cannabis use and vaping. He had lost 70 pounds during this time. New symptoms in the days prior to admission included dizziness […]
Abstract Number: E1
SHM Converge 2022
Background: Systemic muscle relaxant prescriptions have risen in United States. Baclofen is a commonly prescribed muscle relaxant that is gamma-aminobutyric acid (GABA) agonist and renally cleared. We aimed to determine the risk of encephalopathy and mortality associated with baclofen compared to an alternate muscle relaxant cyclobenzaprine in a real-world setting. Methods: We conducted a retrospective […]
Abstract Number: 228
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Rifaximin 550 mg tablets is a nonsystemic antibiotic indicated for reducing the risk of overt hepatic encephalopathy (OHE) recurrence in adults and may be used alone or in combination with the cathartic lactulose. This analysis evaluated the safety profile of rifaximin alone vs rifaximin + lactulose (combination) in patients with cirrhosis. Methods: In a […]
Abstract Number: 309
SHM Converge 2021
Case Presentation: A 40-year-old woman with a history of anxiety presented with one week of diffuse abdominal pain, associated with constipation, decreased oral intake, nausea, and bilious emesis three times a day. She was admitted to an outside hospital one month prior with similar symptoms and treated for pneumonia. The patient lives alone and denied […]
Abstract Number: 312
SHM Converge 2021
Case Presentation: The patient is an immunosuppressed 57 year old male with small bowel and liver transplant due to trauma from a motor vehicle accident 20 years prior and end ileostomy due to anal carcinoma. His chief complaint was “dizziness,” consisting of lightheadedness and diplopia. His wife described three months of progressive forgetfulness and fabricating […]
Abstract Number: 331
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Rifaximin, a nonsystemic antibiotic, may be used alone or in combination with lactulose for reducing the risk of overt hepatic encephalopathy (OHE) recurrence in adults. This analysis evaluated rifaximin alone and rifaximin + lactulose (combination) on health-related quality of life (QOL) and caregiver burden in patients with a history of OHE. Methods: In a […]
Abstract Number: 341
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hepatic encephalopathy (HE) is a common complication in patients with end stage liver disease. Variability in presentation can be a source of clinical uncertainty for medical providers. Ammonia levels have historically been used to aid in the diagnosis of HE despite low positive and negative predictive values. Our primary objective was to determine the […]
Abstract Number: 359
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Hepatic encephalopathy (HE) is a common neurological complication in patients with cirrhosis. In addition to numerous morbidity-related issues, HE is associated with substantial economic burden. Treatment includes lactulose or rifaximin, a nonsystemic antibiotic that is indicated for reducing the risk of overt HE recurrence in adults. Rifaximin has also been shown to reduce the […]
Abstract Number: 379
SHM Converge 2021
Case Presentation: We present a case of a 20-year old male with past medical history of polysubstance abuse and major depressive disorder who was found unresponsive by his roommate in the morning after black tar heroin use. Roommate injected Narcan without effect and called EMS. Roommate reported both the patient and himself were chronic heroin […]
Abstract Number: 392
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Case Presentation: The patient is a 34 y.o. female with a past medical history significant only for morbid obesity. She had a gastric sleeve placed 3 months ago, in order to promote weight loss. Two weeks ago, the patient experienced the onset of blurred vision, clumsiness, ambulatory dysfunction, and generalized weakness. At that time, she […]